spacer
home > pmps > winter 2002 > the environmental impact of metered dose inhalers
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Environmental Impact of Metered Dose Inhalers

Asthma and chronic obstructive pulmonary disease (COPD) are chronic lung diseases and are among the leading causes of morbidity and mortality in the Western world. Asthma is a reversible narrowing of the airways, combined with a chronic inflammation. For reasons largely unknown, the incidence of asthma is rapidly rising. The number of patients increases annually, and today approximately five per cent of the population of the US and Europe suffer from this disease (1-4).

COPD is a chronic inflammation and destruction of the airways. There is a progressive, non-reversible loss of lung function which will eventually lead to invalidity and death. COPD usually occurs in elderly people, of which most are smokers or former smokers (5).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Cees Winnips MD, Director of Business Development at SkyePharma AG
Cornelis 'Cees' Winnips is educated and trained as a physician and began his career in the pharmaceutical industry in 1989 with Ciba-Geigy in the Netherlands. After a short period in the medical department, he moved to the commercial side and worked as Group Product Manager.

In 1993, he relocated to Austria to head the marketing department of Ciba Austria. In 1995, he moved to the Ciba/Novartis head office in Basel, Switzerland as Manager of Business Development, and subsequently became International Product Manager for the respiratory franchise. In 1998, he joined SkyePharma as Director of Business Development.

spacer
Cees Winnips
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AstroNova introduces its range of grass paper labels derived from grass for high quality organic products

Dietzenbach, 29 April 2019, AstroNova GmbH, European headquarters of AstroNova Inc. (RI, USA), responsible for Sales and Customer Service in Europe, the Middle East and Africa (EMEA), is extending its Product Identification range with new approved labelling for direct foodstuff contact.
More info >>

White Papers

Industrial Security in the Pharmaceutical Sector

COPA-DATA

As an attractive target for cyber attacks, pharmaceutical companies need to understand cyber security, assess weak points and implement the appropriate security measures. This white paper describes some of the most effective industrial security tools pharmaceutical companies have at their disposal in the era of Industry 4.0.
More info >>

 
Industry Events

CPhI & P-MEC China

18-20 June 2019, SNIEC, Shanghai, China

CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement